|
Risk of second primary cancer among men with first primary breast cancer |
|||||
| Cancer site |
N |
PERYR |
OBS |
EXP |
SIR (95 percent CI) |
|
|
|||||
| All malignancies, breast included |
1,926 |
8,460.08 |
221 |
190.42 |
1.16 (1.01–1.32) |
| All malignancies, breast excluded |
1,926 |
8,529.63 |
201 |
191.63 |
1.05 (0.91–1.20) |
| Prostate |
1,926 |
8,803.74 |
69 |
72.30 |
0.95(0.74–1.21) |
| Second breast |
1,906 |
8,947.89 |
20 |
0.38 |
52.12 (31.83–80.49) |
| Colorectal |
1,926 |
9,025.49 |
26 |
22.64 |
1.15 (0.75–1.68) |
| Lung and bronchus |
1,926 |
9,065.75 |
23 |
32.76 |
0.70 (0.45–1.05) |
| Bladder |
1,926 |
9,031.02 |
20 |
13.46 |
1.49 (0.91–2.29) |
| Melanomaa |
1,454 |
6,971.11 |
14 |
4.69 |
2.98 (1.63–5.00) |
| Stomach |
1,926 |
9,074.43 |
10 |
4.74 |
2.11 (1.01–3.88) |
|
Bold numbers indicate that the 95 percent confidence interval (CI) does not include 1.00. aNon-Hispanic whites only. EXP, expected; N, number of subjects; OBS, observed; PERYR, person years at risk; SIR, standardized incidence ratios. | |||||
Satram-Hoang et al. Breast Cancer Research 2007 9:R10 doi:10.1186/bcr1643 |
|||||